相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014
Jon E. Zibbell et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement
Ali Mirzazadeh et al.
AIDS AND BEHAVIOR (2018)
Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment
Marianne K. Kringen et al.
THERAPEUTIC DRUG MONITORING (2017)
Current Concepts in Methadone Metabolism and Transport
Evan D. Kharasch
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Simeprevir-induced severe withdrawal syndrome in an HIV/HCV coinfected patient on long-term maintenance methadone therapy
Cristina Gervasoni et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy
Ellen G. J. Hulskotte et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
M. Bosilkovska et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Pharmacokinetic Interaction between Telaprevir and Methadone
Rolf van Heeswijk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
Ulrich M. Zanger et al.
Frontiers in Genetics (2013)
Cytochrome P4503A Does Not Mediate the Interaction between Methadone and Ritonavir-Lopinavir
Evan D. Kharasch et al.
DRUG METABOLISM AND DISPOSITION (2013)
Lack of Indinavir Effects on Methadone Disposition Despite Inhibition of Hepatic and Intestinal Cytochrome P4503A (CYP3A)
Evan D. Kharasch et al.
ANESTHESIOLOGY (2012)
Quantification of human hepatocyte cytochrome P450 enzymes and transporters induced by HIV protease inhibitors using newly validated LC-MS/MS cocktail assays and RT-PCR
Li Liu et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2012)
Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers
V. Michaud et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Stereo-Selective Metabolism of Methadone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s: A Reconciliation
Yan Chang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Complex Drug Interactions of HIV Protease Inhibitors 2: In Vivo Induction and In Vitro to In Vivo Correlation of Induction of Cytochrome P450 1A2, 2B6, and 2C9 by Ritonavir or Nelfinavir
Brian J. Kirby et al.
DRUG METABOLISM AND DISPOSITION (2011)
Complex Drug Interactions of HIV Protease Inhibitors 1: Inactivation, Induction, and Inhibition of Cytochrome P450 3A by Ritonavir or Nelfinavir
Brian J. Kirby et al.
DRUG METABOLISM AND DISPOSITION (2011)
Substitution of (R,S)-Methadone by (R)-Methadone Impact on QTc Interval
Nicolas Ansermot et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir
J. B. Dumond et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Nuclear Receptor-Mediated Induction of CYP450 by Antiretrovirals: Functional Consequences of NR1I2 (PXR) Polymorphisms and Differential Prevalence in Whites and Sub-Saharan Africans
Jenny Svaerd et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Dose-Related Reduction in Bupropion Plasma Concentrations by Ritonavir
Joohyun Park et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Epidemiology of HIV Among Injecting and Non-injecting Drug Users: Current Trends and Implications for Interventions
Steffanie A. Strathdee et al.
Current HIV/AIDS Reports (2010)
Methadone Pharmacokinetics Are Independent of Cytochrome P4503A (CYP3A) Activity and Gastrointestinal Drug Transport Insights from Methadone Interactions with Ritonavir/Indinavir
Evan D. Kharasch et al.
ANESTHESIOLOGY (2009)
Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity
Evan D. Kharasch et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Role of CYP2B6 in stereoselective human methadone metabolism
Rheem A. Totah et al.
ANESTHESIOLOGY (2008)
Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir
Evan D. Kharasch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients
C. Wyen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects
Ping Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Gene-specific effects of inflammatory Cytokines on cytochrome P4502C, 2B6 and 3A4 mRNA levels in human Hepatocytes
Alison E. Aitken et al.
DRUG METABOLISM AND DISPOSITION (2007)
Enantiomeric metabolic interactions and stereoselective human methadone metabolism
Rheem A. Totah et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects
G. W. Hogeland et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Drug interactions between opioids and antiretroviral medications: Interaction between methadone, LAAM, and Delavirdine
EF McCance-Katz et al.
AMERICAN JOURNAL ON ADDICTIONS (2006)
Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers
RE Aarnoutse et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone
ED Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: Noninvasive assessment by use of pupillary miosis
ED Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19
JG Gerber et al.
CHIRALITY (2004)
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro
JS Wang et al.
DRUG METABOLISM AND DISPOSITION (2003)
Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment
CB Eap et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
分享论文
